RecruitingPhase 4NCT07074444
Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel
Studying Clonorchiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Principal Investigator
- Hongliang ZhangFirst Affiliated Hospital of Guangxi Medical University
- Intervention
- Albendazole(drug)
- Enrollment
- 318 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2026
Study locations (2)
- People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
- The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Collaborators
People's Hospital of Guangxi Zhuang Autonomous Region · Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07074444 on ClinicalTrials.gov